Market Overview:
The global seborrhea drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of seborrheic dermatitis, rising awareness about available treatment options, and growing demand for novel therapies. By type, the artemether segment is expected to lead the global seborrhea drugs market during the forecast period. This segment is projected to grow at a CAGR of 6% from 2018 to 2030. By application, hospitals are expected to account for the largest share of the global seborrhea drugs market in 2018.
Product Definition:
Seborrhea is a skin condition that causes the skin to become oily, red, and scaly. Seborrhea drugs are used to treat this condition.
Artemether:
Artemether is a semi-synthetic derivative of the herbal plant artemisia herba. It is an insecticide used to control and prevent malaria in humans and other warm-blooded animals. Artemetherin, one of the active ingredients in artemether, controls malarial parasites by blocking their blood meal intake as well as development on host liver cells.
Hydrogen Peroxide:
Hydrogen peroxide (H2O2) is a chemical compound and an oxidation agent. It is produced by the reaction between hydrogen and oxygen or in other words, it is the combination of water (hydrogen peroxide) and oxygen. The common sources of hydrogen peroxide are found in nature; for instance, fire produces it when fuel meets oxygen.
Application Insights:
The other application segment includes the treatment of tinea corporis, sebostasis, and other skin conditions. The others segment held the largest market share in 2017 due to extensive product usage for various skin conditions such as acne, eczema and psoriasis. In addition, increasing awareness about these disorders is expected to boost product demand over the forecast period.
On the other hand, hospital was estimated as the fastest growing application segment owing to rising prevalence of diseases such as dandruff and scalp itching which are associated with this disorder. Moreover ketoconazole is one of the most effective antifungal agents available for scalp treatment which is anticipated to fuel industry growth during future years.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing prevalence of dermatology conditions and rising awareness about early diagnosis. Moreover, presence of key players such as Pfizer Inc.; Elan Corporation; Johnson & Johnson Services, Inc.; Novartis AG; and Roche Holding Ltd. is also expected to drive the regional growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative CAGR during the forecast period due to growing geriatric population base coupled with high unmet clinical needs pertaining Seborrheic Dermatitis (SD) in this region. In addition, availability of effective generic drugs for artemether will further boost revenue generation in APAC region during the forecast period (2018-2030). However, high incidence rate of HIV/AIDS may hinder growth over certain years owing to low therapeutic index associated with these drugs (TIADL).
Growth Factors:
- Increasing incidence of seborrhea
- Growing awareness about the available treatment options for seborrhea
- Rising demand for better and more effective therapies for seborrhea
- Availability of novel and advanced therapies for the treatment of seborrhea
- Growing number of clinical studies on the efficacy and safety of various drugs used in the treatment of seborrhea
Scope Of The Report
Report Attributes
Report Details
Report Title
Seborrhea Drugs Market Research Report
By Type
Artemether, Hydrogen Peroxide, Ketoconazole, Others
By Application
Hospital, Clinic, Others
By Companies
Aclaris Therapeutics Inc, Amorepacific Corp, Biomar Microbial Technologies, EpiPharm AG, Vyome Biosciences Pvt Ltd, Aclaris Therapeutics Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Seborrhea Drugs Market Report Segments:
The global Seborrhea Drugs market is segmented on the basis of:
Types
Artemether, Hydrogen Peroxide, Ketoconazole, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aclaris Therapeutics Inc
- Amorepacific Corp
- Biomar Microbial Technologies
- EpiPharm AG
- Vyome Biosciences Pvt Ltd
- Aclaris Therapeutics Inc
Highlights of The Seborrhea Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artemether
- Hydrogen Peroxide
- Ketoconazole
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Seborrhea Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Seborrhea drugs are medications used to treat seborrhea, a skin condition that causes excessive oil production. These drugs work by reducing the amount of oil produced by the skin.
Some of the key players operating in the seborrhea drugs market are Aclaris Therapeutics Inc, Amorepacific Corp, Biomar Microbial Technologies, EpiPharm AG, Vyome Biosciences Pvt Ltd, Aclaris Therapeutics Inc.
The seborrhea drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Seborrhea Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Seborrhea Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Seborrhea Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Seborrhea Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Seborrhea Drugs Market Size & Forecast, 2020-2028
4.5.1 Seborrhea Drugs Market Size and Y-o-Y Growth
4.5.2 Seborrhea Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Artemether
5.2.2 Hydrogen Peroxide
5.2.3 Ketoconazole
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Seborrhea Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Seborrhea Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Artemether
9.6.2 Hydrogen Peroxide
9.6.3 Ketoconazole
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Artemether
10.6.2 Hydrogen Peroxide
10.6.3 Ketoconazole
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Artemether
11.6.2 Hydrogen Peroxide
11.6.3 Ketoconazole
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Artemether
12.6.2 Hydrogen Peroxide
12.6.3 Ketoconazole
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Artemether
13.6.2 Hydrogen Peroxide
13.6.3 Ketoconazole
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Seborrhea Drugs Market: Competitive Dashboard
14.2 Global Seborrhea Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aclaris Therapeutics Inc
14.3.2 Amorepacific Corp
14.3.3 Biomar Microbial Technologies
14.3.4 EpiPharm AG
14.3.5 Vyome Biosciences Pvt Ltd
14.3.6 Aclaris Therapeutics Inc
